Loading...
Please wait, while we are loading the content...
Similar Documents
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
| Content Provider | Semantic Scholar |
|---|---|
| Author | Cravedi, Paolo Brusegan, Varusca Ruggenenti, Piero Campbell, Ruth C. Remuzzi, Giuseppe |
| Copyright Year | 2010 |
| Abstract | We have studied the effects of add-on spironolactone treatment (100 mg/day) in 11 patients with idiopathic membranous nephropathy (IMN) and > 3 gm proteinuria/day despite angiotensin converting enzyme (ACE) inhibitor therapy titrated to a systolic/diastolic blood pressure < 120/80 mmHg. Blood pressure, 24-hour urinary protein excretion, and creatinine clearance were measured prior to, after two months of combined therapy, and after a 2-month withdrawal period of spironolactone. While systolic and diastolic blood pressure decreased significantly after spironolactone therapy, proteinuria did not improve. Serum potassium increased significantly as well, with three patients requiring resin-binding therapy. Thus, spironolactone seems to have no additional antiproteinuric effects over ACE inhibitor therapy in patients with IMN and nephrotic syndrome and carries the risk of significant hyperkalemia. |
| Starting Page | 1 |
| Ending Page | 9 |
| Page Count | 9 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.mdpi.com/1424-8247/3/1/1/pdf |
| PubMed reference number | 27713239v1 |
| Volume Number | 3 |
| Journal | Pharmaceuticals |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Angiotensin-Converting Enzyme Inhibitors Angiotensins Creatinine clearance measurement Diastole Idiopathic Membranous Glomerulonephritis Kidney Diseases Nephrotic Syndrome Patients Peptidyl-Dipeptidase A Potassium Resins, Plant Spironolactone Tissue membrane torr |
| Content Type | Text |
| Resource Type | Article |